SpringWorks Therapeutics Reports Interim Data from Phase 2b ReNeu Trial of Mirdametinib for Patients with NF1-PN and Provides Trial Update

NEXT STORY
Pfizer and BioNTech Initiate a Study as Part of Broad Development Plan to Evaluate COVID-19 Booster and New Vaccine Variants
PREV STORY
The global point of care diagnostrics market size is projected to reach USD 50.6 billion by 2025 from USD 29.5 billion in 2020, at a CAGR of 11.4%
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Teleflex Announces Publication of “Pivotal Clinical Study to Evaluate the Safety and Effectiveness of the MANTA Percutaneous Vascular Closure Device”

author_avatar
NASDAQ Market News

Achillion Announces Clearance of Investigational New Drug Application for ACH-5228

author_avatar
NASDAQ Market News

Global Mucormycosis Treatment Market Size to Grow at a CAGR of 8.2 % from 2021 to 2030

author_avatar
NASDAQ Market News